{"id":"https://genegraph.clinicalgenome.org/r/3a914daa-bdd6-48ed-9e36-e5c20b76ba16v1.0","type":"EvidenceStrengthAssertion","dc:description":"The *IFT27* gene is located in chromosome 22q12.3 and encodes the intraflagellar transport (IFT) 27 protein, a small GTPase within IFT complex-B. The protein has a regulatory role in the trafficking of proteins via the Bardet-Biedl Syndrome (BBS) complex (BBsome) into and out of cilia and it is also required for hedgehog signaling. It is ubiquitously expressed at varying levels in all tissues. \n*IFT27* was first reported in relation to BBS in 2014 (Aldahmesh et al., PMID: 24488770). The mechanism of pathogenicity appears to be loss of function. Patients with biallelic *IFT27* pathogenic variants presented with clinical features consistent with ciliopathies, including neurodevelopmental delay, retinitis pigmentosa, kidney disease, obesity, genital anomalies, and polydactyly.\n\nAt least 6 variants (missense, nonsense, frameshift, splice site) have been reported in five probands in five publications (PMIDs: 24488770, 29704304, 29588463, 30761183, 37239474) are included in this curation. The majority of the variants were loss of function. Functional data supports the pathogenicity of a missense variant and a splice site variant (PMIDs: 24488770, 30761183). A total of 7.1 pts. for genetic evidence was reached. \n\nThis gene-disease relationship is also supported by functional studies, expression studies, in vitro assays in non-patient cells, and animal models. Knockout zebrafish model showed typical ciliopathy phenotypes, like laterality defects, body curvature, and cystic kidneys (PMID: 24488770) and knockout mice displayed facial dysmorphism, abnormal palate development, spinal curvature, an abnormal rib cage, congenital heart disease, and various digit defects including polydactyly (PMID: 25446516). BBSome subunits and regulators cannot exit the cilia and instead accumulate in knockout mouse embryonic fibroblasts (PMID: 25446516, 25443296). More evidence is available in the literature, but the maximum score for experimental evidence (6 pts.) was reached. \n\nIn summary, there is definitive evidence supporting the relationship for *IFT27* that we are terming autosomal recessive ciliopathy-*IFT27*. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Kidney Cystic and Ciliopathy Disorders Expert Panel GCEP on the meeting date [February 10, 2025] (SOP Version 11).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/3a914daa-bdd6-48ed-9e36-e5c20b76ba16","GCISnapshot":"https://genegraph.clinicalgenome.org/r/b081d9f6-bf18-4b13-bae4-8a7ed697a350","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/b081d9f6-bf18-4b13-bae4-8a7ed697a350_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10066","date":"2025-02-10T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/b081d9f6-bf18-4b13-bae4-8a7ed697a350_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10066","date":"2025-03-25T15:57:56.151Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b081d9f6-bf18-4b13-bae4-8a7ed697a350_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b540b7c0-5a6d-4a3d-8d67-c5bb079916f2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e19b864f-8ace-4c99-ab93-3593d257af29","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e19b864f-8ace-4c99-ab93-3593d257af29_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29704304","allele":{"id":"https://genegraph.clinicalgenome.org/r/ac224cba-6007-488f-bb7b-a1b83ad14927","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001177701.3(IFT27):c.352+1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10212405"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/7a76ee91-6414-49c2-acbc-1f5fff2e41fe","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7a76ee91-6414-49c2-acbc-1f5fff2e41fe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29704304","allele":{"id":"https://genegraph.clinicalgenome.org/r/904a4cd8-c4ad-4678-b404-6d63b6a9ec49","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001177701.3(IFT27):c.118_125del (p.Thr40GlyfsTer11)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2577704126"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/b540b7c0-5a6d-4a3d-8d67-c5bb079916f2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29704304","rdfs:label":"Proband","allele":[{"id":"https://genegraph.clinicalgenome.org/r/ac224cba-6007-488f-bb7b-a1b83ad14927"},{"id":"https://genegraph.clinicalgenome.org/r/904a4cd8-c4ad-4678-b404-6d63b6a9ec49"}],"firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0000773","obo:HP_0000774","obo:HP_0000811","obo:HP_0012725","obo:HP_0008468","obo:HP_0010958","obo:HP_0100260","obo:HP_0001732","obo:HP_0008751","obo:HP_0005736"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/7a76ee91-6414-49c2-acbc-1f5fff2e41fe_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/e19b864f-8ace-4c99-ab93-3593d257af29_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/a4b405ae-417a-47fe-b0c0-8316b5406986_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a484ab9c-c6c4-4991-9f50-c7a408470625","type":"EvidenceLine","dc:description":"1.5 points were previously given for this variant so I only scored the functional evidence.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a484ab9c-c6c4-4991-9f50-c7a408470625_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Analysis of the patient’s RNA extracted from blood revealed a mix of alternatively spliced isoforms not found in controls (Figures 1B–D). This includes removal of exons 5 + 6 or 4 + 5 + 6 that are predicted to cause an in frame deletion of a significant part of the protein (76 or 96aa out of 185aa).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a484ab9c-c6c4-4991-9f50-c7a408470625_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30761183","allele":{"id":"https://genegraph.clinicalgenome.org/r/ac224cba-6007-488f-bb7b-a1b83ad14927"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b8e96a50-9652-46bc-961d-5831005d841f","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b8e96a50-9652-46bc-961d-5831005d841f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30761183","allele":{"id":"https://genegraph.clinicalgenome.org/r/cb494e63-ddcb-4ea0-a961-dacdb1c233c1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001177701.3(IFT27):c.107A>G (p.Tyr36Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA411386313"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a4b405ae-417a-47fe-b0c0-8316b5406986","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30761183","rdfs:label":"Proband","allele":[{"id":"https://genegraph.clinicalgenome.org/r/cb494e63-ddcb-4ea0-a961-dacdb1c233c1"},{"id":"https://genegraph.clinicalgenome.org/r/ac224cba-6007-488f-bb7b-a1b83ad14927"}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000510","obo:HP_0100259","obo:HP_0011577","obo:HP_0100260","obo:HP_0001513","obo:HP_0001159"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/b8e96a50-9652-46bc-961d-5831005d841f_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/a484ab9c-c6c4-4991-9f50-c7a408470625_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/f9b4b641-4519-4a29-b32a-0c3ae2e0bd7e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a148241f-a6d2-4e4a-93d4-ed8ccf7552ab","type":"EvidenceLine","dc:description":"The score is downgraded because the allelic position of the variants was not confirmed.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a148241f-a6d2-4e4a-93d4-ed8ccf7552ab_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29588463","allele":{"id":"https://genegraph.clinicalgenome.org/r/59cfbb9c-aee4-4181-b1b6-770ba7c4d639","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001177701.3(IFT27):c.353-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA411382212"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/7af3e841-9bf2-4b88-a5ad-a068919b309a","type":"EvidenceLine","dc:description":"The variant was not scored both because it was scored in another family and because family segregation was not studied.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7af3e841-9bf2-4b88-a5ad-a068919b309a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29588463","allele":{"id":"https://genegraph.clinicalgenome.org/r/cb494e63-ddcb-4ea0-a961-dacdb1c233c1"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f9b4b641-4519-4a29-b32a-0c3ae2e0bd7e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29588463","rdfs:label":"RP-2069","allele":[{"id":"https://genegraph.clinicalgenome.org/r/cb494e63-ddcb-4ea0-a961-dacdb1c233c1"},{"id":"https://genegraph.clinicalgenome.org/r/59cfbb9c-aee4-4181-b1b6-770ba7c4d639"}],"firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0001513","obo:HP_0003774","obo:HP_0012759","obo:HP_0010442","obo:HP_0000510"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/7af3e841-9bf2-4b88-a5ad-a068919b309a_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/a148241f-a6d2-4e4a-93d4-ed8ccf7552ab_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/c407cbe3-aa9a-4a1d-b2bd-9f882d5dd0d7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0b1774ff-d396-4b33-9280-a45dff5d0da0","type":"EvidenceLine","dc:description":"Downgraded due to homozygosity","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0b1774ff-d396-4b33-9280-a45dff5d0da0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37239474","allele":{"id":"https://genegraph.clinicalgenome.org/r/22358d50-80c6-4636-99bb-0cdb07dadccb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001177701.3(IFT27):c.97C>T (p.Gln33Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA411386400"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/c407cbe3-aa9a-4a1d-b2bd-9f882d5dd0d7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37239474","rdfs:label":"1A","ageType":"AgeAtReport","ageUnit":"Years","ageValue":12,"allele":{"id":"https://genegraph.clinicalgenome.org/r/22358d50-80c6-4636-99bb-0cdb07dadccb"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0012758","obo:HP_0010442","obo:HP_0001513","obo:HP_0000518","obo:HP_0000486","obo:HP_0000365","obo:HP_0000077","obo:HP_0000483","obo:HP_0000546","obo:HP_0001251"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/0b1774ff-d396-4b33-9280-a45dff5d0da0_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/b8b139d3-01cb-469f-a70b-8e27ede08af6_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f1d4fd68-2896-4577-9b09-ce28a7c29d5d","type":"EvidenceLine","dc:description":"Downgraded due to homozygosity","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f1d4fd68-2896-4577-9b09-ce28a7c29d5d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Figure 6.C100Y substitution affects the stability of Ift27. (A) GFP signal in 7.5-h post-fertilization embryos injected with ift27 GFP (WT) or ift27 C100Y GFP (C100Y) mRNA. (B) Western blot showing the level of Ift27-GFP (WT) or Ift27 C100Y GFP (C100Y) in whole embryo lysates. Embryos were injected with two independent batches of mRNAs. Tubulin was used as a loading control.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/f1d4fd68-2896-4577-9b09-ce28a7c29d5d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24488770","allele":{"id":"https://genegraph.clinicalgenome.org/r/bd97c49a-bbfe-40ce-8cbe-052c0739cb2c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001177701.3(IFT27):c.299G>A (p.Cys100Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA163415"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b8b139d3-01cb-469f-a70b-8e27ede08af6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24488770","rdfs:label":"BBS_DG7a","allele":{"id":"https://genegraph.clinicalgenome.org/r/bd97c49a-bbfe-40ce-8cbe-052c0739cb2c"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"\n","phenotypes":["obo:HP_0000458","obo:HP_0001627","obo:HP_0000510","obo:HP_0000089","obo:HP_0001249","obo:HP_0010442","obo:HP_0001513","obo:HP_0001999","obo:HP_0001397"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/f1d4fd68-2896-4577-9b09-ce28a7c29d5d_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":7.1},{"id":"https://genegraph.clinicalgenome.org/r/b081d9f6-bf18-4b13-bae4-8a7ed697a350_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b081d9f6-bf18-4b13-bae4-8a7ed697a350_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/90dfd066-adf4-4101-b2ca-4b08c0a4af1a","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dddaf0dd-b781-475f-bf17-a4bb65bfeacb","type":"Finding","dc:description":"The skeletal anomalies, digit defects, and cardiac anomalies are also seen in ciliopathies.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25446516","rdfs:label":"Ift27 null mutants display multiple developmental defects","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/bb60c1ca-5dfb-4155-b927-8d8919c979de","type":"EvidenceLine","dc:description":"We reached 4 max points for Model-Rescue evidence","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7f65cd5e-0467-44be-bcdf-038e0785244e","type":"Finding","dc:description":"infertility and hypogonadism are common phenotypes in ciliopathies","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28964737","rdfs:label":"In Ift27 mutants, axoneme and microtubules are disrupted.","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/386f399c-1798-440a-a709-f9c509ab8b35","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/809e6721-b43a-46fa-8d01-66f5e87dd08a","type":"Finding","dc:description":"These phenotypes in zebrafish are known to be associated with ciliopathies","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24488770","rdfs:label":"Zebrafish embryos co-injected with morpholino","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/b081d9f6-bf18-4b13-bae4-8a7ed697a350_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/502d03b7-7ba1-4fbf-aee8-21fe689a59dc","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/99fc6977-53f4-4d1e-9df5-aa3cb4f7172b","type":"FunctionalAlteration","dc:description":"Loss of IFT27 causes hyperaccumulation of ARL6 and BBSome in cilia","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25443296","rdfs:label":"Loss of IFT27 causes hyperaccumulation of ARL6 in cilia"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/45ef5330-5d3b-4088-9d9f-5c5e814ed34c","type":"EvidenceLine","dc:description":"We reached 1 max points for \tFunctional Alteration Non-patient cells\t","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5062d6ed-60cb-4f61-a7ea-0326d719f44f","type":"FunctionalAlteration","dc:description":"In IFT27-KO cells, ARL6 accumulates in cilia. \n\nThis experiment also includes rescue evidence (I did not score because we already reached highest score): Expression of IFT27(WT) reduces this ARL6 level, while expression of the IFT27(C100Y) or IFT27(Y36C) variants does not affect ARL6 levels. This suggests that only functional IFT27 (IFT27(WT)) is able to regulate the ciliary ARL6 accumulation, while the defective variants cannot achieve this regulation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34888642","rdfs:label":"IFT27 variants cannot rescue ciliary BBSome accumulation"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/6aa9a873-9f94-4b23-8b93-9c8b7c593908","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/66c8d377-bbe3-430b-a4c0-caf2bc8c70a4","type":"FunctionalAlteration","dc:description":"BBSome subunits BBS5, BBS9 and BBS regulators Arl6, Lztfl1 accumulate in Ift27 mutant cilia\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25446516","rdfs:label":"BBSome subunits regulators accumulate in Ift27 mutant cilia"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b081d9f6-bf18-4b13-bae4-8a7ed697a350_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/97ce8b88-9d7b-4eed-9210-c9c34850d6c9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c7e2f8d-3191-4543-a0b6-beb352ea3631","type":"Finding","dc:description":"Jin et al. (2010) showed that ARL6 binds a ciliary complex with 7 BBS proteins and BBIP10, and its GTP-bound form recruits the complex to cilia. ARL6's N-terminal helix binds lipid liposomes, leading to the polymerization of the complex into a planar coat, which aids in lateral transport of cargo to ciliary membranes. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25443296","rdfs:label":" IFT27 Stabilizes the Nucleotide-Empty Form of ARL6","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b0ed5189-d44d-4d94-8ed5-adf3d970a003","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/333d1300-9174-447c-818e-381d2103de24","type":"Finding","dc:description":"ARL6 is also implicated for ciliopathies https://www.omim.org/entry/608845 ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25443296","rdfs:label":"Identification of ARL6 as an interactor of IFT27","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":10105,"specifiedBy":"GeneValidityCriteria11","strengthScore":13.1,"subject":{"id":"https://genegraph.clinicalgenome.org/r/NaF_gcZFm7g","type":"GeneValidityProposition","disease":"obo:MONDO_0005308","gene":"hgnc:18626","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_b081d9f6-bf18-4b13-bae4-8a7ed697a350-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}